A correlation of magnetisation transfer ratio histogram measures with clinical disease severity in inherited prion disease by Siddique, D, Wroe, S, Hyare, H, Webb, T, Pal, S, Collinge, J, Walker, S, Yousry, T, Thornton, J

PRION-1 TRIAL: Therapies for human prion disease (ISRCTN06722585) by Wroe, S, Thomas, D, Rossor, M, Walker, A, Keogh, G, Siddique, D, Webb, T, Pal, S, Darbyshire, J, Collinge, J

Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1. by Carswell, C, Rañopa, M, Pal, S, Macfarlane, R, Siddique, D, Thomas, D, Webb, T, Wroe, S, Walker, S, Darbyshire, J, Collinge, J, Mead, S, Rudge, P

Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseases. by Siddique, D, Hyare, H, Wroe, S, Webb, T, Macfarlane, R, Rudge, P, Collinge, J, Powell, C, Brandner, S, So, P, Walker, S, Mead, S, Yousry, T, Thornton, J

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. by Collinge, J, Gorham, M, Hudson, F, Kennedy, A, Keogh, G, Pal, S, Rossor, M, Rudge, P, Siddique, D, Spyer, M, Thomas, D, Walker, S, Webb, T, Wroe, S, Darbyshire, J

Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. by Webb, T, Poulter, M, Beck, J, Uphill, J, Adamson, G, Campbell, T, Linehan, J, Powell, C, Brandner, S, Pal, S, Siddique, D, Wadsworth, J, Joiner, S, Alner, K, Petersen, C, Hampson, S, Rhymes, C, Treacy, C, Storey, E, Geschwind, MD, Nemeth, A, Wroe, S, Collinge, J, Mead, S